Altered HDL proteome predicts incident CVD in chronic kidney disease patients
Patients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional lipid risk factors, including low HDL levels, cannot completely explain the increased risk. Altered HDL proteome is linked with both CVD and CKD, but the role of HDL proteins in incident CVD events in patients...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-01-01
|
| Series: | Journal of Lipid Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227521001176 |
| _version_ | 1798026730068246528 |
|---|---|
| author | Baohai Shao Anna V. Mathew Carissa Thornock Subramaniam Pennathur Matthias Kretzler Debbie Gipson Markus Bitzer Crystal Gadegbeku Keith Bellovich Zeenat Bhat Susan Massengill Kalyani Perumal |
| author_facet | Baohai Shao Anna V. Mathew Carissa Thornock Subramaniam Pennathur Matthias Kretzler Debbie Gipson Markus Bitzer Crystal Gadegbeku Keith Bellovich Zeenat Bhat Susan Massengill Kalyani Perumal |
| author_sort | Baohai Shao |
| collection | DOAJ |
| description | Patients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional lipid risk factors, including low HDL levels, cannot completely explain the increased risk. Altered HDL proteome is linked with both CVD and CKD, but the role of HDL proteins in incident CVD events in patients with CKD is unknown. In this prospective case-control study, we used targeted proteomics to quantify 31 HDL proteins in 92 subjects (46 incident new CVD and 46 one-to-one matched controls) at various stages of CKD. We tested associations of HDL proteins with incident CVD using matched logistic regression analysis. In the model fully adjusted for clinical confounders, lipid levels, C-reactive protein, and proteinuria, no significant associations were found for HDL-C, but we observed inverse associations between levels of HDL proteins paraoxonase/arylesterase 1 (PON1), paraoxonase/arylesterase 3 (PON3), and LCAT and incident CVD. Odds ratios (per 1 SD) were 0.38 (0.18–0.97, P = 0.042), 0.42 (0.20–0.92, P = 0.031), and 0.30 (0.11–0.83, P = 0.020) for PON1, PON3, and LCAT, respectively. Apolipoprotein A-IV remained associated with incident CVD in CKD patients in models adjusted for clinical confounders and lipid levels but lost significance with the addition of C-reactive protein and proteinuria to the model. In conclusion, levels of four HDL proteins, PON1, PON3, LCAT, and apolipoprotein A-IV, were found to be inversely associated with incident CVD events in CKD patients. Our observations indicate that HDLs' protein cargo, but not HDL-C levels, can serve as a marker—and perhaps mediator—for elevated CVD risk in CKD patients. |
| first_indexed | 2024-04-11T18:40:04Z |
| format | Article |
| id | doaj.art-b4aa4d551b3048118677416168a82eca |
| institution | Directory Open Access Journal |
| issn | 0022-2275 |
| language | English |
| last_indexed | 2024-04-11T18:40:04Z |
| publishDate | 2021-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Lipid Research |
| spelling | doaj.art-b4aa4d551b3048118677416168a82eca2022-12-22T04:09:02ZengElsevierJournal of Lipid Research0022-22752021-01-0162100135Altered HDL proteome predicts incident CVD in chronic kidney disease patientsBaohai Shao0Anna V. Mathew1Carissa Thornock2Subramaniam Pennathur3Matthias KretzlerDebbie GipsonMarkus BitzerCrystal GadegbekuKeith BellovichZeenat BhatSusan MassengillKalyani PerumalDepartment of Medicine, UW Medicine Diabetes Institute, University of Washington, Seattle, WA, USA; For correspondence: Baohai Shao; Subramaniam PennathurDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USADepartment of Medicine, UW Medicine Diabetes Institute, University of Washington, Seattle, WA, USADivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA; For correspondence: Baohai Shao; Subramaniam PennathurPatients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional lipid risk factors, including low HDL levels, cannot completely explain the increased risk. Altered HDL proteome is linked with both CVD and CKD, but the role of HDL proteins in incident CVD events in patients with CKD is unknown. In this prospective case-control study, we used targeted proteomics to quantify 31 HDL proteins in 92 subjects (46 incident new CVD and 46 one-to-one matched controls) at various stages of CKD. We tested associations of HDL proteins with incident CVD using matched logistic regression analysis. In the model fully adjusted for clinical confounders, lipid levels, C-reactive protein, and proteinuria, no significant associations were found for HDL-C, but we observed inverse associations between levels of HDL proteins paraoxonase/arylesterase 1 (PON1), paraoxonase/arylesterase 3 (PON3), and LCAT and incident CVD. Odds ratios (per 1 SD) were 0.38 (0.18–0.97, P = 0.042), 0.42 (0.20–0.92, P = 0.031), and 0.30 (0.11–0.83, P = 0.020) for PON1, PON3, and LCAT, respectively. Apolipoprotein A-IV remained associated with incident CVD in CKD patients in models adjusted for clinical confounders and lipid levels but lost significance with the addition of C-reactive protein and proteinuria to the model. In conclusion, levels of four HDL proteins, PON1, PON3, LCAT, and apolipoprotein A-IV, were found to be inversely associated with incident CVD events in CKD patients. Our observations indicate that HDLs' protein cargo, but not HDL-C levels, can serve as a marker—and perhaps mediator—for elevated CVD risk in CKD patients.http://www.sciencedirect.com/science/article/pii/S0022227521001176CVDcase-control studyCKDHDLHDL-C levelsHDL proteomics |
| spellingShingle | Baohai Shao Anna V. Mathew Carissa Thornock Subramaniam Pennathur Matthias Kretzler Debbie Gipson Markus Bitzer Crystal Gadegbeku Keith Bellovich Zeenat Bhat Susan Massengill Kalyani Perumal Altered HDL proteome predicts incident CVD in chronic kidney disease patients Journal of Lipid Research CVD case-control study CKD HDL HDL-C levels HDL proteomics |
| title | Altered HDL proteome predicts incident CVD in chronic kidney disease patients |
| title_full | Altered HDL proteome predicts incident CVD in chronic kidney disease patients |
| title_fullStr | Altered HDL proteome predicts incident CVD in chronic kidney disease patients |
| title_full_unstemmed | Altered HDL proteome predicts incident CVD in chronic kidney disease patients |
| title_short | Altered HDL proteome predicts incident CVD in chronic kidney disease patients |
| title_sort | altered hdl proteome predicts incident cvd in chronic kidney disease patients |
| topic | CVD case-control study CKD HDL HDL-C levels HDL proteomics |
| url | http://www.sciencedirect.com/science/article/pii/S0022227521001176 |
| work_keys_str_mv | AT baohaishao alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT annavmathew alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT carissathornock alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT subramaniampennathur alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT matthiaskretzler alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT debbiegipson alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT markusbitzer alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT crystalgadegbeku alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT keithbellovich alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT zeenatbhat alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT susanmassengill alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients AT kalyaniperumal alteredhdlproteomepredictsincidentcvdinchronickidneydiseasepatients |